@article {Kudryashova2020.09.30.20199943, author = {Olga B. Kudryashova and Evgeny V. Muravlev and Alexandra A. Antonnikova}, title = {Propagation of Viral Bioaerosols Indoors}, elocation-id = {2020.09.30.20199943}, year = {2020}, doi = {10.1101/2020.09.30.20199943}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Here we look into the spread of aerosols indoors that may potentially carry viruses. Many viruses, including the novel Covid-19, are known to spread via airborne and air-dust pathways. From the literature data and our own research on the propagation of fine aerosols, we simulate herein the carryover of viral aerosols in indoor air. We demonstrate that a great deal of fine droplets released from an infected person{\textquoteright}s coughing, sneezing or talking propagate very fast and to large distances indoors, as well as bend around obstacles, lift up and down over staircases, and so on. This study suggests equations to evaluate the concentration of those droplets, depending on time and distance from the source of infection. Estimates are given for the safe distance to the source of infection, and available methods for neutralizing viral aerosols indoors are considered.Competing Interest StatementThe authors have declared no competing interest.Funding Statementnot applicableAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesnot applicable}, URL = {https://www.medrxiv.org/content/early/2020/09/30/2020.09.30.20199943}, eprint = {https://www.medrxiv.org/content/early/2020/09/30/2020.09.30.20199943.full.pdf}, journal = {medRxiv} }